konjac .bio
Buyer guide

Glucomannan Supplement Manufacturing Guide

B2B guide to glucomannan supplement manufacturing: grades, EFSA claims, GMP partners, testing, NDI basics, EU status, and label files.

Glucomannan supplement manufacturing is a B2B formulation, compliance, and quality-control decision. Brands should specify the right konjac-derived glucomannan grade, choose a GMP-aligned contract manufacturer, document EFSA or U.S. label claims, and test disintegration, dispersion, viscosity, microbiology, and serving uniformity before launch.
No. 01

How should brands specify glucomannan supplement manufacturing grades?

Brands should specify glucomannan supplement manufacturing grades by dosage format, viscosity, particle size, hydration speed, microbial limits, and intended daily serving.

Glucomannan is a water-soluble polysaccharide from the corm of Amorphophallus konjac, commonly called konjac, and its hydration behavior is central to supplement performance konjac review. A capsule formula may need controlled swelling and reliable disintegration. A stick-pack powder may need rapid dispersion without clumping.

FormatPreferred grade focusBuyer specification
CapsulesFine powder, controlled viscosity, low dustParticle size range, capsule fill weight, disintegration result, microbial limits
Bulk powdersHigh viscosity, neutral taste, low odorViscosity method, mesh size, moisture, ash, heavy metals, serving size
Ready-to-mix sticksFast-dispersing agglomerated powderWettability, flowability, sachet weight variance, flavor compatibility
Blended fiber formulasCompatible hydration profileBlend uniformity, interaction with inulin, psyllium, gums, minerals, or sweeteners

A useful purchase specification includes identity testing, purity targets, moisture, viscosity method, particle size, microbiology, allergens, pesticide screen, residual solvents if used, heavy metals, country of origin, and storage conditions. For related raw-material context, see glucomannan, konjac, and konjac powder.

No. 02

Which EFSA claims can a glucomannan supplement manufacturing brief use?

A glucomannan supplement manufacturing brief for the EU can use authorized EFSA-linked wording only when the product meets the required conditions of use.

For weight management, the exact authorized wording is: "Consumption of glucomannan in the context of an energy-restricted diet contributes to weight loss." EFSA evaluated the claim for glucomannan and body weight in adults EFSA opinion, and the EU authorized wording appears in Commission Regulation 432/2012 EU register.

For cholesterol maintenance, the authorized wording is: "contributes to the maintenance of normal blood cholesterol levels" at a daily intake of at least 4 g of glucomannan, with the relevant EFSA assessment covering blood cholesterol maintenance EFSA cholesterol.

Claim areaRequired wordingCommercial check
Weight managementConsumption of glucomannan in the context of an energy-restricted diet contributes to weight lossConfirm daily dose, dose timing, water-use directions, and local-language translation
Blood cholesterol maintenancecontributes to the maintenance of normal blood cholesterol levelsConfirm at least 4 g glucomannan per day and retain claim support in the label file

Do not broaden EFSA wording into unsupported outcomes. A compliant label file should connect the exact claim, serving size, daily intake, instructions for use, warning language, and the finished-product specification.

No. 03

Capsules, powders, and ready-to-mix sticks: manufacturing tradeoffs

Each finished format changes the manufacturing risk profile. The same konjac glucomannan raw material can behave differently in a hard capsule, a scoopable powder, and a flavored stick pack.

Capsules are compact and familiar, but glucomannan swells in water, so disintegration and use directions matter. Capsule projects usually prioritize fill-weight accuracy, excipient compatibility, and packaging that limits moisture pickup.

Powders can deliver larger servings with fewer units, which matters when a claim requires grams per day. Powder projects should control clumping, mouthfeel, serving scoop accuracy, hydration speed, flavor masking, and container headspace.

Ready-to-mix sticks are convenient for travel and sampling. Stick packs need excellent flow through sachet equipment, low electrostatic behavior, tight net-weight controls, and a dispersion profile that works in the consumer's stated water volume. For noodle and food-format comparisons, see shirataki noodles and konjac wholesale.

No. 04

How do GMP-certified contract manufacturers control glucomannan quality?

GMP-certified contract manufacturers control glucomannan quality through written specifications, qualified suppliers, batch records, in-process checks, finished-product testing, and release documentation.

In the United States, dietary supplement current good manufacturing practice requirements are codified in 21 CFR Part 111, covering areas such as production records, quality control operations, packaging, labeling, and holding 21 CFR 111. A strong contract manufacturer can show how those controls are applied to a high-hydration fiber ingredient.

For global programs, ISO 22000 can support food-safety management systems across the supply chain ISO 22000. ISO certification does not replace local supplement rules, but it helps standardize hazard analysis, supplier controls, and traceability.

  • Ask for a current GMP certificate or audit summary.
  • Request a master manufacturing record for each SKU.
  • Confirm identity testing on incoming glucomannan.
  • Review sanitation, metal detection, allergen, and environmental controls.
  • Require deviation, nonconformance, and recall procedures.
  • Confirm retained samples and batch-release authority.
No. 05

What dissolution and disintegration testing should brands request?

Brands should request capsule disintegration, powder dispersion, viscosity development, serving uniformity, moisture, and microbiology testing for every commercial glucomannan format.

Dietary supplement methods often reference compendial approaches such as USP dietary supplement chapters for performance and quality expectations USP supplements. For glucomannan, a practical test plan also needs format-specific checks because hydration can change the consumer experience within minutes.

TestWhy it mattersTypical buyer question
Capsule disintegrationConfirms capsule shell opening under defined conditionsWhat method, medium, time, and acceptance limit are used?
Powder dispersionAssesses clumping and mixability in the stated water volumeHow many inversions, seconds, or stir cycles are required?
ViscosityConfirms grade consistency and hydration performanceWhat concentration, temperature, spindle, and timing define the result?
Serving uniformityVerifies capsule, scoop, or stick-pack deliveryWhat is the acceptance range for net weight or active fiber amount?
Moisture and water activitySupports flow, stability, and microbial controlWhat limits trigger investigation or rejection?

Use directions should be consistent with the tested format. A label that tells consumers to use a specific water volume should be supported by dispersion and hydration data at that volume.

No. 06

Regulatory checkpoints: DSHEA, NDI, and EU Novel Food status

Regulatory review should start before formulation lock because ingredient history, claim wording, dose, format, and market geography can change the launch path.

In the United States, DSHEA established the dietary supplement framework for products containing vitamins, minerals, herbs, amino acids, and other dietary ingredients DSHEA overview. FDA's New Dietary Ingredient process applies when a dietary ingredient was not marketed in the United States before October 15, 1994, unless an exemption applies NDI background.

For the EU, Novel Food review depends on whether the food or ingredient was consumed to a significant degree before May 15, 1997, plus the specific production process and intended use Novel Food. A konjac-derived ingredient may have different status depending on purification, particle engineering, concentration, and finished format.

  • Document U.S. market history for the exact glucomannan ingredient.
  • Check whether the supplier has an NDI position or notification history.
  • Review EU ingredient status for the exact process and use level.
  • Align claims with jurisdiction-specific wording and dose conditions.
  • Keep regulatory memos in the product technical file.
No. 07

How should a brand build a label-claim substantiation file?

A brand should build a label-claim substantiation file that links every claim to ingredient identity, daily dose, finished-product testing, compliant wording, and supporting evidence.

For U.S. marketing, the Federal Trade Commission expects competent and reliable support for objective product claims, with evidence quality matched to the claim type FTC guidance. For EU marketing, authorized nutrition and health claims must follow the permitted wording and conditions of use in the EU framework EU claims.

A complete glucomannan label file usually includes:

  1. Finished-product formula and master manufacturing record.
  2. Raw-material specification and supplier qualification file.
  3. Certificates of analysis for each batch.
  4. Identity, microbiology, heavy metal, moisture, and viscosity results.
  5. Disintegration or dispersion test reports for the finished format.
  6. Claim rationale showing daily glucomannan intake.
  7. Artwork review with serving size, directions, cautions, and jurisdiction-specific wording.
  8. Stability plan and retained-sample policy.

Do not rely on raw-material marketing sheets alone. A finished capsule, powder, or stick pack needs its own records because processing, excipients, fill weights, and packaging can affect the delivered serving.

No. 08

Procurement checklist for selecting a manufacturing partner

A disciplined procurement process reduces launch delays and helps brands compare suppliers on evidence rather than promises.

Use the same request-for-quote template for every contract manufacturer. Ask for the target serving size, target viscosity grade, minimum order quantity, lead time, packaging format, testing scope, regulatory documents, allergen controls, and change-control process.

QuestionStrong answerRisk signal
Can you run high-hydration fibers?Shows prior glucomannan or soluble-fiber batchesOnly general powder experience
How is viscosity tested?Defines concentration, temperature, instrument, and timeReports a number without method details
Who releases batches?Quality unit reviews records before shipmentSales team controls release timing
How are claims reviewed?Regulatory review links claims to dose and wordingGeneric label review with no claim file
How are supplier changes handled?Written notification and requalification processIngredient substitutions without prior approval

Before issuing a purchase order, request pilot samples, accelerated stability data if available, a full testing quote, packaging specifications, and a clear ownership statement for formulas, labels, and batch documentation.

Q&A

Frequently asked questions

01 What is the best format for a glucomannan supplement brand?
The best format depends on daily dose, consumer routine, and claim strategy. Capsules are compact but may require multiple units to reach gram-level servings. Powders and ready-to-mix sticks can deliver larger servings more easily, but they need dispersion, flavor, and clump-control work. If an EU weight-management claim is planned, the finished format must support the required daily intake and use directions tied to the authorized wording in Commission Regulation 432/2012 EU claims.
02 Can a U.S. brand use the EFSA glucomannan weight-management claim?
A U.S. brand should not copy EU wording onto a U.S. label without a separate U.S. regulatory review. EFSA-linked wording applies to the EU framework, while U.S. dietary supplement labeling is governed by DSHEA, FDA rules, and advertising standards. FDA describes DSHEA as the U.S. framework for dietary supplements DSHEA overview. U.S. structure/function statements need substantiation and the required label handling for that market.
03 What daily amount is needed for the EU cholesterol-maintenance claim?
The EU cholesterol-maintenance claim for glucomannan requires at least 4 g per day, and the authorized wording is "contributes to the maintenance of normal blood cholesterol levels." EFSA evaluated glucomannan in relation to normal blood cholesterol maintenance EFSA cholesterol. A brand should confirm that the serving size, number of daily servings, directions, and finished-product assay all support the 4 g daily intake.
04 What documents should a contract manufacturer provide before launch?
A qualified contract manufacturer should provide a master manufacturing record, batch record template, finished-product specification, raw-material specification, COAs, identity test plan, microbiology limits, heavy metal limits, packaging specification, stability plan, and quality agreement. In the U.S., 21 CFR Part 111 sets supplement CGMP requirements for production, quality control, packaging, labeling, and holding 21 CFR 111. Brands should review these documents before commercial production.
05 Is glucomannan always exempt from FDA NDI review?
No. FDA's NDI process depends on whether the exact dietary ingredient was marketed in the United States before October 15, 1994, and whether the current ingredient, process, or use differs in a way that affects regulatory status. FDA explains the NDI framework for dietary supplements in its industry background materials NDI background. Brands should request supplier history, manufacturing process details, and a written regulatory position.
06 Does EU Novel Food status depend only on the plant source?
No. EU Novel Food status can depend on the ingredient's history of consumption, production process, concentration, intended use, and finished format. The European Commission states that Novel Food status relates to foods not consumed to a significant degree in the EU before May 15, 1997 Novel Food. A brand should review the exact glucomannan ingredient, not only the botanical source.
07 Why is viscosity testing important for glucomannan supplements?
Viscosity testing confirms whether the selected glucomannan grade performs consistently after hydration. The method must define concentration, water temperature, mixing time, instrument, spindle, speed, and reading time because different methods can give different results. This matters for capsules, powders, and sticks because hydration speed affects consumer experience, manufacturing flow, and serving consistency. Buyers should require viscosity data on the raw material and, when relevant, on the finished blend.
08 What should be in a glucomannan label-claim file?
A glucomannan label-claim file should include claim wording, jurisdiction, daily glucomannan intake, formula, test results, COAs, label artwork, use directions, cautions, and supporting evidence. For U.S. advertising, FTC expects objective claims to be supported by competent and reliable evidence appropriate to the claim FTC guidance. For EU claims, the file should map the exact wording to authorized conditions of use.
Sources
  1. Scientific Opinion on glucomannan and body weight · EFSA · 2010
  2. Scientific Opinion on glucomannan and blood cholesterol maintenance · EFSA · 2009
  3. Commission Regulation 432/2012 on permitted health claims · European Union · 2012
  4. Dietary supplement current good manufacturing practice, 21 CFR Part 111 · eCFR · 2024
  5. New Dietary Ingredients in Dietary Supplements · FDA · 2024
  6. Dietary Supplement Health and Education Act of 1994 · FDA · 2024
  7. Novel Food Catalogue · European Commission · 2024
  8. ISO 22000 food safety management · ISO · 2018
Wholesale & private label

Need a glucomannan manufacturing specification?

konjac.bio can help B2B teams compare glucomannan grades, supplier documents, testing plans, and claim files before they brief a contract manufacturer.